4/9
05:21 pm
antx
Form S-3 AN2 Therapeutics, Inc.
Low
Report
Form S-3 AN2 Therapeutics, Inc.
4/9
05:04 pm
antx
Form 8-K AN2 Therapeutics, Inc. For: Apr 09
Low
Report
Form 8-K AN2 Therapeutics, Inc. For: Apr 09
3/25
04:42 pm
antx
Form D AN2 Therapeutics, Inc.
Low
Report
Form D AN2 Therapeutics, Inc.
3/23
07:17 pm
antx
Form 4 AN2 Therapeutics, Inc. For: Mar 19 Filed by: Day Lucy
Low
Report
Form 4 AN2 Therapeutics, Inc. For: Mar 19 Filed by: Day Lucy
3/23
07:16 pm
antx
Form 4 AN2 Therapeutics, Inc. For: Mar 19 Filed by: Chanda Sanjay
Low
Report
Form 4 AN2 Therapeutics, Inc. For: Mar 19 Filed by: Chanda Sanjay
3/23
07:14 pm
antx
Form 4 AN2 Therapeutics, Inc. For: Mar 19 Filed by: Marks Gilbert Lynn
Low
Report
Form 4 AN2 Therapeutics, Inc. For: Mar 19 Filed by: Marks Gilbert Lynn
3/23
07:11 pm
antx
Form 4 AN2 Therapeutics, Inc. For: Mar 19 Filed by: Aziz Kabeer
Low
Report
Form 4 AN2 Therapeutics, Inc. For: Mar 19 Filed by: Aziz Kabeer
3/23
07:10 pm
antx
Form 4 AN2 Therapeutics, Inc. For: Mar 19 Filed by: Martin Patricia A.
Low
Report
Form 4 AN2 Therapeutics, Inc. For: Mar 19 Filed by: Martin Patricia A.
3/23
07:10 pm
antx
Form 4 AN2 Therapeutics, Inc. For: Mar 19 Filed by: FitzPatrick Margaret M
Low
Report
Form 4 AN2 Therapeutics, Inc. For: Mar 19 Filed by: FitzPatrick Margaret M
3/23
07:08 pm
antx
Form 4 AN2 Therapeutics, Inc. For: Mar 19 Filed by: Wong Stephanie
Low
Report
Form 4 AN2 Therapeutics, Inc. For: Mar 19 Filed by: Wong Stephanie
3/23
07:08 pm
antx
Form 4 AN2 Therapeutics, Inc. For: Mar 19 Filed by: Zakrzewski Joseph S
Low
Report
Form 4 AN2 Therapeutics, Inc. For: Mar 19 Filed by: Zakrzewski Joseph S
3/23
07:06 pm
antx
Form 4 AN2 Therapeutics, Inc. For: Mar 19 Filed by: Eizen Joshua M
Low
Report
Form 4 AN2 Therapeutics, Inc. For: Mar 19 Filed by: Eizen Joshua M
3/23
07:04 pm
antx
Form 4 AN2 Therapeutics, Inc. For: Mar 19 Filed by: Spigelman Melvin K
Low
Report
Form 4 AN2 Therapeutics, Inc. For: Mar 19 Filed by: Spigelman Melvin K
3/23
07:02 pm
antx
Form 4 AN2 Therapeutics, Inc. For: Mar 19 Filed by: Readnour Robin Shane
Low
Report
Form 4 AN2 Therapeutics, Inc. For: Mar 19 Filed by: Readnour Robin Shane
3/23
07:00 pm
antx
Form 4 AN2 Therapeutics, Inc. For: Mar 19 Filed by: Easom Eric
Low
Report
Form 4 AN2 Therapeutics, Inc. For: Mar 19 Filed by: Easom Eric
3/20
04:37 pm
antx
Form 8-K AN2 Therapeutics, Inc. For: Mar 19
Low
Report
Form 8-K AN2 Therapeutics, Inc. For: Mar 19
3/17
04:10 pm
antx
Form S-8 AN2 Therapeutics, Inc.
Medium
Report
Form S-8 AN2 Therapeutics, Inc.
3/17
04:04 pm
antx
Form 10-K AN2 Therapeutics, Inc. For: Dec 31
Medium
Report
Form 10-K AN2 Therapeutics, Inc. For: Dec 31
3/17
04:02 pm
antx
Form 8-K AN2 Therapeutics, Inc. For: Mar 17
Medium
Report
Form 8-K AN2 Therapeutics, Inc. For: Mar 17
3/16
04:21 pm
antx
Form SCHEDULE 13G AN2 Therapeutics, Inc. Filed by: Commodore Capital LP
Medium
Report
Form SCHEDULE 13G AN2 Therapeutics, Inc. Filed by: Commodore Capital LP
3/13
05:02 pm
antx
Form SCHEDULE 13G AN2 Therapeutics, Inc. Filed by: INTEGRATED CORE STRATEGIES (US) LLC
Medium
Report
Form SCHEDULE 13G AN2 Therapeutics, Inc. Filed by: INTEGRATED CORE STRATEGIES (US) LLC
3/13
04:02 pm
antx
Form SCHEDULE 13G AN2 Therapeutics, Inc. Filed by: Vivo Opportunity Fund Holdings, L.P.
Medium
Report
Form SCHEDULE 13G AN2 Therapeutics, Inc. Filed by: Vivo Opportunity Fund Holdings, L.P.
3/10
06:03 am
antx
Form 8-K AN2 Therapeutics, Inc. For: Mar 08
High
Report
Form 8-K AN2 Therapeutics, Inc. For: Mar 08
3/5
06:55 pm
antx
Form 4 AN2 Therapeutics, Inc. For: Mar 03 Filed by: Williams Sarah Joanne
High
Report
Form 4 AN2 Therapeutics, Inc. For: Mar 03 Filed by: Williams Sarah Joanne
2/23
04:41 pm
antx
Form 4 AN2 Therapeutics, Inc. For: Feb 20 Filed by: Eizen Joshua M
Low
Report
Form 4 AN2 Therapeutics, Inc. For: Feb 20 Filed by: Eizen Joshua M